This study successfully developed and optimized CLE lozenges using the QbD approach. The results suggest that this herbal product can be further scaled up to pilot and production levels for potential use as a smoking cessation aid.
Chankana et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: